Evidence map›Paper›PMID 40035915›Full record

ArticleBrain tumor pathology2025

Visualizing the endothelial glycocalyx in human glioma vasculature.

Kazufumi Ohmura, Hiroyuki Tomita, Hideshi Okada, Noriyuki Nakayama, Naoyuki Ohe, Tsuyoshi Izumo, Akira Hara

Abstract read
In one paragraph

Article in Brain tumor pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kazufumi OhmuraDepartment of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan.
Hiroyuki TomitaDepartment of Tumor Pathology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan. tomita.hiroyuki.y6@f.gifu-u.ac.jp.ORCID http://orcid.org/0000-0002-3291-0274
Hideshi OkadaCenter for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Gifu, Japan. okada.hideshi.a4@f.gifu-u.ac.jp.
Noriyuki NakayamaDepartment of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan.
Naoyuki OheDepartment of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan.
Tsuyoshi IzumoDepartment of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan.
Akira HaraDepartment of Tumor Pathology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan.

Funding

JSPS KAKENHI JP20K0758723JSPS KAKENHI JP 22K09203JSPS KAKENHI JP23H03326JSPS KAKENHI JP 24K19545JST FOREST Program JPMJFR220W
6 · The paper itself

Abstract

Gliomas are the most common primary brain tumors in adults. However, glioblastoma is especially difficult to treat despite advancements in treatment. Therefore, new and more effective treatments are needed. The endothelial glycocalyx covers the luminal surface of the endothelium and plays an important role in vascular homeostasis. Tumor blood vessels normally have increased permeability, but some of them mimic normal cerebral blood vessels constituting the blood-brain barrier and retain drug-barrier function. Therefore, brain tumor vessels are considered to constitute the blood-tumor barrier. There are few reports on the endothelial glycocalyx in human brain tumor vessels. We aimed to visualize the endothelial glycocalyx in human brain tumor vessels and evaluate its microstructural differences in glioma vessels and normal capillaries. Surgical specimens from patients with glioma who underwent tumor resection at our institution were evaluated. We visualized the microstructures of the brain tumor vessels in human glioma specimens using electron microscopy with lanthanum nitrate. The endothelial glycocalyx was identified in the human glioma vasculature and its microstructure varied between the tumor margin and core. These variations may influence tumor angiogenesis and vascular remodeling, contributing to advancements in targeted therapies and diagnostics for human gliomas.

Indexed as

Brain NeoplasmsEndothelium, VascularGliomaGlycocalyxNeovascularization, PathologicAdultAgedBlood-Brain BarrierFemaleHumansMaleMiddle AgedBlood–brain barrierBlood–tumor barrierElectron microscopyEndothelial glycocalyxGlioblastomaGlioma

Identifiers

PMID40035915
PMCPMC11993481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.